États-Unis · Plateformes & données · TipRanks

Supernus–Indivior Deal Faces Dividend Financing Risk as Citibank Term Loan Remains Uncertain

Publié par TipRanks · États-Unis il y a 11 h

Supernus Pharmaceuticals (SUPN) has disclosed a new risk, in the Debt & Financing category. Supernus Pharmaceuticals faces risk that the debt financing intended to ...

Lire l'article complet sur TipRanks Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.tipranks.com)

Supernus–Indivior Deal Faces Dividend Financing Risk as Citibank Term Loan Remains Uncertain

À lire aussi

Here's What $10,000 Invested Equally in SpaceX and Nvidia Could Be Worth in 2030

Morguard Real Estate Inv. Q3 Earnings Call Highlights

SoftBank-backed OPay cancels $304M U.S. IPO over regulatory inquiry - Bloomberg

Grand Theft Callout: ‘GTA 6’ fans are missing work on the game’s release day because they ‘don’t want to wait’ anymore

Data Center Spending Will Surge to $1.4 Trillion in 2027. Here’s 1 Stock to Buy With $500 to Capitalize on This Massive Opportunity

Hong Kong telecom company agrees to halt U.S. operations under pressure

Supernus–Indivior Deal Faces Dividend Financing Risk as Citibank Term Loan Remains Uncertain

Partager

À lire aussi

Here's What $10,000 Invested Equally in SpaceX and Nvidia Could Be Worth in 2030

Morguard Real Estate Inv. Q3 Earnings Call Highlights

SoftBank-backed OPay cancels $304M U.S. IPO over regulatory inquiry - Bloomberg

Grand Theft Callout: ‘GTA 6’ fans are missing work on the game’s release day because they ‘don’t want to wait’ anymore

Data Center Spending Will Surge to $1.4 Trillion in 2027. Here’s 1 Stock to Buy With $500 to Capitalize on This Massive Opportunity

Hong Kong telecom company agrees to halt U.S. operations under pressure